Please login to the form below

Not currently logged in

Kleemann joins Merck from Boehringer

Appointed head of group tax

Pharma finance veteran Sylvia Kleemann is to leave Boehringer Ingelheim to join rival German pharma firm Merck KGaA as head of group tax at the beginning of 2014.

Kleeman served as head of corporate tax at Boehringer and has additional life sciences experience at KPMG, Celanese and Fresenius Medical Care.

In her new role, she will report to chief financial officer Matthias Zachert. She replaces Armin Gembruch who has been head of group tax since May 2011.

Zachert said: “Sylvia Kleemann has extensive experience in both the pharmaceutical and the chemical industries. At the same time, Sylvia Kleemann has a very broad understanding of both public and family-owned companies, which makes her ideally suited for her new position at Merck.”

3rd December 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....